To that extent, this launch adds to Lupin’s FY26 revenues. The company derived nearly one-third of its revenue from the US market in the nine months ended December (9MFY25).

Only a 2-hour ferry from the US coast, explore crystal clear waters, conch salad and snorkel a shipwreck ...

It was recently discovered 132 years after its demise. The ship was found approximately 60 miles northwest of Whitefish Point in Lake Superior. According to The Great Lakes Shipwreck Historical ...

32,404 people played the daily Crossword recently. Can you solve it faster than others?32,404 people played the daily Crossword recently. Can you solve it faster than others?

Lupin's shares increased by 21.51% over the past year. However, year-to-date (YTD), the stock has decreased by 14.21%. Over the last six months, the price fell by 10.12%, while in the past three ...

Mumbai: Global pharma major Lupin Limited has announced that it has launched Rivaroxaban Tablets USP, 2.5 mg, following the final approval of its Abbreviated New Drug Application (ANDA) from the US ...

Lake Tekapo (New Zealand) From mid-spring to early summer, wild lupin flowers paint South Island’s Lake Tekapo in various shades of purple. The best time to capture this purplish panorama is in ...

Drug firm Lupin Ltd on Friday (March 7) said it has launched rivaroxaban tablets USP, 2.5 mg, in the US market following final approval from the US Food and Drug Administration (FDA) for its ...

Lupin Ltd. shares rose on Wednesday, after Citi gave the stock a double upgrade to 'buy' rating, driven by expectations of sustained margin strength. This is set to be fueled by good momentum from US ...

With its vivid turquoise, green and blue waters, it’s no surprise Lake Salda is often promoted as the “Maldives of Turkey.” Extraordinary to look at, peaceful and surrounded by an abundance ...

Mumbai: Global pharma major Lupin Limited has announced its inclusion in prestigious S&P Global Sustainability Yearbook 2025, for the second consecutive year. Lupin has been included in the Top 10% ...